History of chemotherapy of leprosy

Clinics in Dermatology

Volumn 34, Issue 1, 2016, Pages 32-36

  Noordeen, Shaik K ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACEDAPSONE; CLARITHROMYCIN; ETHIONAMIDE; ISONIAZID; PROTIONAMIDE; QUINOLONE DERIVATIVE; RIFAMPICIN; RIFAPENTINE; SULFALENE; SULFONAMIDE; THIAMBUTOSINE; THIOACETAZONE; LEPROSTATIC AGENT;

ARTICLE; BACTERICIDAL ACTIVITY; CHEMOTHERAPY; DRUG EFFICACY; DRUG SAFETY; DRUG USE; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; LEPROSY; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; RELAPSE; TREATMENT DURATION; TREATMENT FAILURE; COMBINATION DRUG THERAPY; HISTORY;

DRUG THERAPY, COMBINATION; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; LEPROSTATIC AGENTS; LEPROSY;

EID: 84953426260     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2015.10.016     Document Type: Article

References (32)

1. Schujman S. Therapeutic value of Chaulmoogra in the treatment of leprosy. Int J Lepr 1947, 15:135-143.
2. Levy L. The activity of chaulmoogra acids against the M. leprae. Am Rev Respir Dis 1975, 111:703-705.
3. Faget S.H., Johansen F.A., Ross H. Sulphonamide in the treatment of leprosy. Public Health Rep 1942, 57:1892-1899.
4. Languillon J. Résultat du traitement spécifique de la lèpre par les sulfamides-retard à L'Institut Marchoux (Bamako-Mali). Acta Leprol 1969, 34/35:45-56.
5. Faget S.H., Pogge R.C., Johnson F.A., et al. The Promin treatment of leprosy: A progress report. Public Health Rep 1943, 58:1729-1741.
6. Cochrane R.G., Ramanujam K., Paul H., Russel D. Two and a half years of experimental work on sulphone group of drugs. Lepr Rev 1949, 20:4-64.
7. Lowe J., Smith M. The chemotherapy of leprosy in Nigeria. Int J Lepr 1949, 17:181-195.
8. Shepard C.C., Mc Rae D.H., Habas J.A. Sensitivity of M. leprae to low levels of DDS. Proc Soc Exp Biol Med 1966, 122:893-896.
9. Shepard C.C., Chang Y.T. Effect of several anti leprosy drugs on multiplication of human leprosy bacilli in the foot pad of mice. Proc Soc Exp Biol Med 1962, 109:636-638.
10. Shepard C.C., Tolentino J.G., McRae R.H. The therapeutic effect of DADDS in leprosy. Am J Trop Med Hyg 1968, 17:192-201.
11. Russel D.A., Shepard C.C., McRae J.H., et al. Treatment with DADDS of leprosy patients in Karimui, New Guinea. Am J Trop Med Hyg 1971, 20:495-501.
12. Petit J.H.S., Rees R.J.W., Ridley D.S. Studies on sulphone resistence in leprosy in experimental and clinical study. Lancet 1966, 26:673-674.
13. Baohong J. Drug resistance in leprosy-a review. Lepr Rev 1985, 56:265-278.
14. Browne S.G., Hogerzeil L.M. B663 in the treatment of leprosy: Supplementary report of the pilot trial. Lepr Rev 1962, 33(1):182-184.
15. Opromolla D.V.A. First results of the use of rifamycin SV in the treatment of leprosy. Trans VIII Int Lepr Congr (Rio de Janeiro) 1963, 2:346-355.
16. Rees R.J.W., Pearson J.M.H., Waters M.F.R. Experimental and clinical studies in on rifampicin in the treatment of leprosy. Br Med J 1982, 1:89-92.
17. Shepard C.C., Levy L., Fasal P. Rapid bactericidal effect of rifampicin on M. leprae. Am J Trop Med Hyg 1972, 21:446.
18. Pattyn S.R., Rollier R., Saerens E.J., et al. Initial three months continuous and intermittent therapy in lepromatous leprosy. A controlled clinical trial-preliminary data. Ann Soc Belg Med Trop 1974, 54:43-49.
19. Floch H.A., Rist N., Jacobi J.C. Interest in ethionamide in anti-leprosy therapy. Bull Soc Pathol Exot 1966, 59:715-724.
20. Freerksen E., Rosenfeld M. Leprosy eradication project in Malta-first published report after 5 years. Chemotherapy 1977, 23:356-386.
21. Isoprodian Group Does isoniazid increase hepatotoxicity of the combination protionamide-dapsone?. Int J Lepr 1992, 60:536-541.
22. WHO Expert Committee on Leprosy. Fifth Report TRS 607 1976, World Health Organization, Geneva, Switzerland.
23. Tenth International Leprosy Congress Reports of committees. Lepr Rev 1974, 45:41-73.
24. LEPRA Drugs to combat drug resistance-notes prepared following the Heathrow meeting. ILEP London 1977, 1.
25. Proceedings of the First International Workshop on Chemotherapy of Leprosy, Manila 1977, Sasakawa Memorial Health Foundation, Tokyo, Japan.
26. Chemotherapy of Leprosy for Control Programmes Study Group. WHO Technical Report Series-TRS675. Geneva, Switzerland: World Health Organization.
27. WHO Expert Committee on Leprosy. Sixth Report-TRS 768 1988, World Health Organization, Geneva, Switzerland.
28. WHO Expert Committee on Leprosy. Seventh Report-TRS 874 1998, World Health Organization, Geneva, Switzerland.
29. WHO Study Group on Chemotherapy of Leprosy TRS 847 1994, World Health Organization, Geneva, Switzerland.
30. WHO Expert Committee on Leprosy. Eighth Report-TRS 968 2012, World Health Organization, Geneva, Switzerland.
31. Noordeen S.K. Leprosy control through multi drug therapy (MDT). Bull WHO 1991, 69:263-269.
32. Leprosy Resolution WHA. 44.9. Forty-fourth World Health Assembly, 13 May 1991, World Health Organization, Geneva, Switzerland.